Therapeutic base editing in the adult liver
- PMID: 34285418
- DOI: 10.1038/s41575-021-00491-9
Therapeutic base editing in the adult liver
Comment on
-
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates.Nature. 2021 May;593(7859):429-434. doi: 10.1038/s41586-021-03534-y. Epub 2021 May 19. Nature. 2021. PMID: 34012082
-
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels.Nat Biotechnol. 2021 Aug;39(8):949-957. doi: 10.1038/s41587-021-00933-4. Epub 2021 May 19. Nat Biotechnol. 2021. PMID: 34012094 Free PMC article.
References
-
- Anzalone, A. V. et al. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824–844 (2020). - DOI
-
- Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. https://doi.org/10.1038/s41587-021-00933-4 (2021). - DOI - PubMed
-
- Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429–434 (2021). - DOI
-
- Song, C.-Q. et al. Adenine base editing in an adult mouse model of tyrosinaemia. Nat. Biomed. Eng. 4 (2020).
-
- Villiger, L. et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat. Med. 24, 1519–1525 (2018). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
